Early public adherence with and support for stay-at-home COVID-19 mitigation strategies despite adverse life impact: a transnational cross-sectional survey study in the United States and Australia

Background Governments worldwide recommended unprecedented measures to contain the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As pressure mounted to scale back measures, understanding public priorities was critical. We assess...

Full description

Saved in:
Bibliographic Details
Published inBMC public health Vol. 21; no. 1; pp. 503 - 16
Main Authors Czeisler, Mark É., Howard, Mark E., Robbins, Rebecca, Barger, Laura K., Facer-Childs, Elise R., Rajaratnam, Shantha M. W., Czeisler, Charles A.
Format Journal Article
LanguageEnglish
Published London BioMed Central 15.03.2021
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1471-2458
1471-2458
DOI10.1186/s12889-021-10410-x

Cover

Abstract Background Governments worldwide recommended unprecedented measures to contain the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As pressure mounted to scale back measures, understanding public priorities was critical. We assessed initial public adherence with and support for stay-at-home orders in nations and cities with different SARS-CoV-2 infection and COVID-19 death rates. Methods Cross-sectional surveys were administered to representative samples of adults aged ≥18 years from regions with different SARS-CoV-2 prevalences from April 2–8, 2020. Regions included two nations [the United States (US—high prevalence) and Australia (AU—low prevalence)] and two US cities [New York City (NY—high prevalence) and Los Angeles (LA—low prevalence)]. Regional SARS-CoV-2 and COVID-19 prevalence (cumulative SARS-CoV-2 infections, COVID-19 deaths) as of April 8, 2020: US (363,321, 10,845), AU (5956, 45), NY (81,803, 4571), LA (7530, 198). Of 8718 eligible potential respondents, 5573 (response rate, 63.9%) completed surveys. Median age was 47 years (range, 18–89); 3039 (54.5%) were female. Results Of 5573 total respondents, 4560 (81.8%) reported adherence with recommended quarantine or stay-at-home policies (range of samples, 75.5–88.2%). Additionally, 29.1% of respondents screened positive for anxiety or depression symptoms (range of samples, 28.6–32.0%), with higher prevalences among those of younger age, female gender, and those in quarantine or staying at home most of the time versus those who did not report these behaviours. Despite elevated prevalences of adverse mental health symptoms and significant life disruptions, 5022 respondents (90.1%) supported government-imposed stay-at-home orders (range of samples, 88.9–93.1%). Of these, 90.8% believed orders should last at least three more weeks or until public health or government officials recommended, with support spanning the political spectrum. Conclusions Public adherence with COVID-19 mitigation policies was highly prevalent, in both highly-affected (US, NY) and minimally-affected regions (AU, LA). Despite disruption of respondents’ lives, the vast majority supported continuation of extended stay-at-home orders. Despite common support, these two countries diverged in stringent mitigation implementation, which may have contributed to subsequent outcomes. These results reveal the importance of surveillance of public support for and adherence with such policies during the COVID-19 pandemic and for future infectious disease outbreaks.
AbstractList Background Governments worldwide recommended unprecedented measures to contain the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As pressure mounted to scale back measures, understanding public priorities was critical. We assessed initial public adherence with and support for stay-at-home orders in nations and cities with different SARS-CoV-2 infection and COVID-19 death rates. Methods Cross-sectional surveys were administered to representative samples of adults aged [greater than or equai to]18 years from regions with different SARS-CoV-2 prevalences from April 2-8, 2020. Regions included two nations [the United States (US--high prevalence) and Australia (AU--low prevalence)] and two US cities [New York City (NY--high prevalence) and Los Angeles (LA--low prevalence)]. Regional SARS-CoV-2 and COVID-19 prevalence (cumulative SARS-CoV-2 infections, COVID-19 deaths) as of April 8, 2020: US (363,321, 10,845), AU (5956, 45), NY (81,803, 4571), LA (7530, 198). Of 8718 eligible potential respondents, 5573 (response rate, 63.9%) completed surveys. Median age was 47 years (range, 18-89); 3039 (54.5%) were female. Results Of 5573 total respondents, 4560 (81.8%) reported adherence with recommended quarantine or stay-at-home policies (range of samples, 75.5-88.2%). Additionally, 29.1% of respondents screened positive for anxiety or depression symptoms (range of samples, 28.6-32.0%), with higher prevalences among those of younger age, female gender, and those in quarantine or staying at home most of the time versus those who did not report these behaviours. Despite elevated prevalences of adverse mental health symptoms and significant life disruptions, 5022 respondents (90.1%) supported government-imposed stay-at-home orders (range of samples, 88.9-93.1%). Of these, 90.8% believed orders should last at least three more weeks or until public health or government officials recommended, with support spanning the political spectrum. Conclusions Public adherence with COVID-19 mitigation policies was highly prevalent, in both highly-affected (US, NY) and minimally-affected regions (AU, LA). Despite disruption of respondents' lives, the vast majority supported continuation of extended stay-at-home orders. Despite common support, these two countries diverged in stringent mitigation implementation, which may have contributed to subsequent outcomes. These results reveal the importance of surveillance of public support for and adherence with such policies during the COVID-19 pandemic and for future infectious disease outbreaks. Keywords: COVID-19, Coronavirus, SARS-CoV-2, Pandemic, Stay-at-home orders, Mitigation strategies, Mental health, Insomnia, Public health policy, Qualtrics
Governments worldwide recommended unprecedented measures to contain the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As pressure mounted to scale back measures, understanding public priorities was critical. We assessed initial public adherence with and support for stay-at-home orders in nations and cities with different SARS-CoV-2 infection and COVID-19 death rates. Cross-sectional surveys were administered to representative samples of adults aged ≥18 years from regions with different SARS-CoV-2 prevalences from April 2-8, 2020. Regions included two nations [the United States (US-high prevalence) and Australia (AU-low prevalence)] and two US cities [New York City (NY-high prevalence) and Los Angeles (LA-low prevalence)]. Regional SARS-CoV-2 and COVID-19 prevalence (cumulative SARS-CoV-2 infections, COVID-19 deaths) as of April 8, 2020: US (363,321, 10,845), AU (5956, 45), NY (81,803, 4571), LA (7530, 198). Of 8718 eligible potential respondents, 5573 (response rate, 63.9%) completed surveys. Median age was 47 years (range, 18-89); 3039 (54.5%) were female. Of 5573 total respondents, 4560 (81.8%) reported adherence with recommended quarantine or stay-at-home policies (range of samples, 75.5-88.2%). Additionally, 29.1% of respondents screened positive for anxiety or depression symptoms (range of samples, 28.6-32.0%), with higher prevalences among those of younger age, female gender, and those in quarantine or staying at home most of the time versus those who did not report these behaviours. Despite elevated prevalences of adverse mental health symptoms and significant life disruptions, 5022 respondents (90.1%) supported government-imposed stay-at-home orders (range of samples, 88.9-93.1%). Of these, 90.8% believed orders should last at least three more weeks or until public health or government officials recommended, with support spanning the political spectrum. Public adherence with COVID-19 mitigation policies was highly prevalent, in both highly-affected (US, NY) and minimally-affected regions (AU, LA). Despite disruption of respondents' lives, the vast majority supported continuation of extended stay-at-home orders. Despite common support, these two countries diverged in stringent mitigation implementation, which may have contributed to subsequent outcomes. These results reveal the importance of surveillance of public support for and adherence with such policies during the COVID-19 pandemic and for future infectious disease outbreaks.
Background Governments worldwide recommended unprecedented measures to contain the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As pressure mounted to scale back measures, understanding public priorities was critical. We assessed initial public adherence with and support for stay-at-home orders in nations and cities with different SARS-CoV-2 infection and COVID-19 death rates. Methods Cross-sectional surveys were administered to representative samples of adults aged ≥18 years from regions with different SARS-CoV-2 prevalences from April 2–8, 2020. Regions included two nations [the United States (US—high prevalence) and Australia (AU—low prevalence)] and two US cities [New York City (NY—high prevalence) and Los Angeles (LA—low prevalence)]. Regional SARS-CoV-2 and COVID-19 prevalence (cumulative SARS-CoV-2 infections, COVID-19 deaths) as of April 8, 2020: US (363,321, 10,845), AU (5956, 45), NY (81,803, 4571), LA (7530, 198). Of 8718 eligible potential respondents, 5573 (response rate, 63.9%) completed surveys. Median age was 47 years (range, 18–89); 3039 (54.5%) were female. Results Of 5573 total respondents, 4560 (81.8%) reported adherence with recommended quarantine or stay-at-home policies (range of samples, 75.5–88.2%). Additionally, 29.1% of respondents screened positive for anxiety or depression symptoms (range of samples, 28.6–32.0%), with higher prevalences among those of younger age, female gender, and those in quarantine or staying at home most of the time versus those who did not report these behaviours. Despite elevated prevalences of adverse mental health symptoms and significant life disruptions, 5022 respondents (90.1%) supported government-imposed stay-at-home orders (range of samples, 88.9–93.1%). Of these, 90.8% believed orders should last at least three more weeks or until public health or government officials recommended, with support spanning the political spectrum. Conclusions Public adherence with COVID-19 mitigation policies was highly prevalent, in both highly-affected (US, NY) and minimally-affected regions (AU, LA). Despite disruption of respondents’ lives, the vast majority supported continuation of extended stay-at-home orders. Despite common support, these two countries diverged in stringent mitigation implementation, which may have contributed to subsequent outcomes. These results reveal the importance of surveillance of public support for and adherence with such policies during the COVID-19 pandemic and for future infectious disease outbreaks.
Governments worldwide recommended unprecedented measures to contain the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As pressure mounted to scale back measures, understanding public priorities was critical. We assessed initial public adherence with and support for stay-at-home orders in nations and cities with different SARS-CoV-2 infection and COVID-19 death rates. Cross-sectional surveys were administered to representative samples of adults aged [greater than or equai to]18 years from regions with different SARS-CoV-2 prevalences from April 2-8, 2020. Regions included two nations [the United States (US--high prevalence) and Australia (AU--low prevalence)] and two US cities [New York City (NY--high prevalence) and Los Angeles (LA--low prevalence)]. Regional SARS-CoV-2 and COVID-19 prevalence (cumulative SARS-CoV-2 infections, COVID-19 deaths) as of April 8, 2020: US (363,321, 10,845), AU (5956, 45), NY (81,803, 4571), LA (7530, 198). Of 8718 eligible potential respondents, 5573 (response rate, 63.9%) completed surveys. Median age was 47 years (range, 18-89); 3039 (54.5%) were female. Of 5573 total respondents, 4560 (81.8%) reported adherence with recommended quarantine or stay-at-home policies (range of samples, 75.5-88.2%). Additionally, 29.1% of respondents screened positive for anxiety or depression symptoms (range of samples, 28.6-32.0%), with higher prevalences among those of younger age, female gender, and those in quarantine or staying at home most of the time versus those who did not report these behaviours. Despite elevated prevalences of adverse mental health symptoms and significant life disruptions, 5022 respondents (90.1%) supported government-imposed stay-at-home orders (range of samples, 88.9-93.1%). Of these, 90.8% believed orders should last at least three more weeks or until public health or government officials recommended, with support spanning the political spectrum. Public adherence with COVID-19 mitigation policies was highly prevalent, in both highly-affected (US, NY) and minimally-affected regions (AU, LA). Despite disruption of respondents' lives, the vast majority supported continuation of extended stay-at-home orders. Despite common support, these two countries diverged in stringent mitigation implementation, which may have contributed to subsequent outcomes. These results reveal the importance of surveillance of public support for and adherence with such policies during the COVID-19 pandemic and for future infectious disease outbreaks.
Governments worldwide recommended unprecedented measures to contain the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As pressure mounted to scale back measures, understanding public priorities was critical. We assessed initial public adherence with and support for stay-at-home orders in nations and cities with different SARS-CoV-2 infection and COVID-19 death rates.BACKGROUNDGovernments worldwide recommended unprecedented measures to contain the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As pressure mounted to scale back measures, understanding public priorities was critical. We assessed initial public adherence with and support for stay-at-home orders in nations and cities with different SARS-CoV-2 infection and COVID-19 death rates.Cross-sectional surveys were administered to representative samples of adults aged ≥18 years from regions with different SARS-CoV-2 prevalences from April 2-8, 2020. Regions included two nations [the United States (US-high prevalence) and Australia (AU-low prevalence)] and two US cities [New York City (NY-high prevalence) and Los Angeles (LA-low prevalence)]. Regional SARS-CoV-2 and COVID-19 prevalence (cumulative SARS-CoV-2 infections, COVID-19 deaths) as of April 8, 2020: US (363,321, 10,845), AU (5956, 45), NY (81,803, 4571), LA (7530, 198). Of 8718 eligible potential respondents, 5573 (response rate, 63.9%) completed surveys. Median age was 47 years (range, 18-89); 3039 (54.5%) were female.METHODSCross-sectional surveys were administered to representative samples of adults aged ≥18 years from regions with different SARS-CoV-2 prevalences from April 2-8, 2020. Regions included two nations [the United States (US-high prevalence) and Australia (AU-low prevalence)] and two US cities [New York City (NY-high prevalence) and Los Angeles (LA-low prevalence)]. Regional SARS-CoV-2 and COVID-19 prevalence (cumulative SARS-CoV-2 infections, COVID-19 deaths) as of April 8, 2020: US (363,321, 10,845), AU (5956, 45), NY (81,803, 4571), LA (7530, 198). Of 8718 eligible potential respondents, 5573 (response rate, 63.9%) completed surveys. Median age was 47 years (range, 18-89); 3039 (54.5%) were female.Of 5573 total respondents, 4560 (81.8%) reported adherence with recommended quarantine or stay-at-home policies (range of samples, 75.5-88.2%). Additionally, 29.1% of respondents screened positive for anxiety or depression symptoms (range of samples, 28.6-32.0%), with higher prevalences among those of younger age, female gender, and those in quarantine or staying at home most of the time versus those who did not report these behaviours. Despite elevated prevalences of adverse mental health symptoms and significant life disruptions, 5022 respondents (90.1%) supported government-imposed stay-at-home orders (range of samples, 88.9-93.1%). Of these, 90.8% believed orders should last at least three more weeks or until public health or government officials recommended, with support spanning the political spectrum.RESULTSOf 5573 total respondents, 4560 (81.8%) reported adherence with recommended quarantine or stay-at-home policies (range of samples, 75.5-88.2%). Additionally, 29.1% of respondents screened positive for anxiety or depression symptoms (range of samples, 28.6-32.0%), with higher prevalences among those of younger age, female gender, and those in quarantine or staying at home most of the time versus those who did not report these behaviours. Despite elevated prevalences of adverse mental health symptoms and significant life disruptions, 5022 respondents (90.1%) supported government-imposed stay-at-home orders (range of samples, 88.9-93.1%). Of these, 90.8% believed orders should last at least three more weeks or until public health or government officials recommended, with support spanning the political spectrum.Public adherence with COVID-19 mitigation policies was highly prevalent, in both highly-affected (US, NY) and minimally-affected regions (AU, LA). Despite disruption of respondents' lives, the vast majority supported continuation of extended stay-at-home orders. Despite common support, these two countries diverged in stringent mitigation implementation, which may have contributed to subsequent outcomes. These results reveal the importance of surveillance of public support for and adherence with such policies during the COVID-19 pandemic and for future infectious disease outbreaks.CONCLUSIONSPublic adherence with COVID-19 mitigation policies was highly prevalent, in both highly-affected (US, NY) and minimally-affected regions (AU, LA). Despite disruption of respondents' lives, the vast majority supported continuation of extended stay-at-home orders. Despite common support, these two countries diverged in stringent mitigation implementation, which may have contributed to subsequent outcomes. These results reveal the importance of surveillance of public support for and adherence with such policies during the COVID-19 pandemic and for future infectious disease outbreaks.
Abstract Background Governments worldwide recommended unprecedented measures to contain the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As pressure mounted to scale back measures, understanding public priorities was critical. We assessed initial public adherence with and support for stay-at-home orders in nations and cities with different SARS-CoV-2 infection and COVID-19 death rates. Methods Cross-sectional surveys were administered to representative samples of adults aged ≥18 years from regions with different SARS-CoV-2 prevalences from April 2–8, 2020. Regions included two nations [the United States (US—high prevalence) and Australia (AU—low prevalence)] and two US cities [New York City (NY—high prevalence) and Los Angeles (LA—low prevalence)]. Regional SARS-CoV-2 and COVID-19 prevalence (cumulative SARS-CoV-2 infections, COVID-19 deaths) as of April 8, 2020: US (363,321, 10,845), AU (5956, 45), NY (81,803, 4571), LA (7530, 198). Of 8718 eligible potential respondents, 5573 (response rate, 63.9%) completed surveys. Median age was 47 years (range, 18–89); 3039 (54.5%) were female. Results Of 5573 total respondents, 4560 (81.8%) reported adherence with recommended quarantine or stay-at-home policies (range of samples, 75.5–88.2%). Additionally, 29.1% of respondents screened positive for anxiety or depression symptoms (range of samples, 28.6–32.0%), with higher prevalences among those of younger age, female gender, and those in quarantine or staying at home most of the time versus those who did not report these behaviours. Despite elevated prevalences of adverse mental health symptoms and significant life disruptions, 5022 respondents (90.1%) supported government-imposed stay-at-home orders (range of samples, 88.9–93.1%). Of these, 90.8% believed orders should last at least three more weeks or until public health or government officials recommended, with support spanning the political spectrum. Conclusions Public adherence with COVID-19 mitigation policies was highly prevalent, in both highly-affected (US, NY) and minimally-affected regions (AU, LA). Despite disruption of respondents’ lives, the vast majority supported continuation of extended stay-at-home orders. Despite common support, these two countries diverged in stringent mitigation implementation, which may have contributed to subsequent outcomes. These results reveal the importance of surveillance of public support for and adherence with such policies during the COVID-19 pandemic and for future infectious disease outbreaks.
Background Governments worldwide recommended unprecedented measures to contain the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As pressure mounted to scale back measures, understanding public priorities was critical. We assessed initial public adherence with and support for stay-at-home orders in nations and cities with different SARS-CoV-2 infection and COVID-19 death rates. Methods Cross-sectional surveys were administered to representative samples of adults aged ≥18 years from regions with different SARS-CoV-2 prevalences from April 2–8, 2020. Regions included two nations [the United States (US—high prevalence) and Australia (AU—low prevalence)] and two US cities [New York City (NY—high prevalence) and Los Angeles (LA—low prevalence)]. Regional SARS-CoV-2 and COVID-19 prevalence (cumulative SARS-CoV-2 infections, COVID-19 deaths) as of April 8, 2020: US (363,321, 10,845), AU (5956, 45), NY (81,803, 4571), LA (7530, 198). Of 8718 eligible potential respondents, 5573 (response rate, 63.9%) completed surveys. Median age was 47 years (range, 18–89); 3039 (54.5%) were female. Results Of 5573 total respondents, 4560 (81.8%) reported adherence with recommended quarantine or stay-at-home policies (range of samples, 75.5–88.2%). Additionally, 29.1% of respondents screened positive for anxiety or depression symptoms (range of samples, 28.6–32.0%), with higher prevalences among those of younger age, female gender, and those in quarantine or staying at home most of the time versus those who did not report these behaviours. Despite elevated prevalences of adverse mental health symptoms and significant life disruptions, 5022 respondents (90.1%) supported government-imposed stay-at-home orders (range of samples, 88.9–93.1%). Of these, 90.8% believed orders should last at least three more weeks or until public health or government officials recommended, with support spanning the political spectrum. Conclusions Public adherence with COVID-19 mitigation policies was highly prevalent, in both highly-affected (US, NY) and minimally-affected regions (AU, LA). Despite disruption of respondents’ lives, the vast majority supported continuation of extended stay-at-home orders. Despite common support, these two countries diverged in stringent mitigation implementation, which may have contributed to subsequent outcomes. These results reveal the importance of surveillance of public support for and adherence with such policies during the COVID-19 pandemic and for future infectious disease outbreaks.
ArticleNumber 503
Audience Academic
Author Howard, Mark E.
Rajaratnam, Shantha M. W.
Robbins, Rebecca
Czeisler, Mark É.
Czeisler, Charles A.
Barger, Laura K.
Facer-Childs, Elise R.
Author_xml – sequence: 1
  givenname: Mark É.
  orcidid: 0000-0003-3100-7347
  surname: Czeisler
  fullname: Czeisler, Mark É.
  email: mark.czeisler@fulbrightmail.org
  organization: Turner Institute for Brain and Mental Health, Monash University, Institute for Breathing and Sleep, Austin Health, Department of Psychiatry, Brigham and Women’s Hospital
– sequence: 2
  givenname: Mark E.
  orcidid: 0000-0001-7772-1496
  surname: Howard
  fullname: Howard, Mark E.
  organization: Turner Institute for Brain and Mental Health, Monash University, Institute for Breathing and Sleep, Austin Health, Department of Medicine, University of Melbourne
– sequence: 3
  givenname: Rebecca
  orcidid: 0000-0003-0288-2505
  surname: Robbins
  fullname: Robbins, Rebecca
  organization: Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women’s Hospital, Division of Sleep Medicine, Harvard Medical School
– sequence: 4
  givenname: Laura K.
  orcidid: 0000-0001-8547-7331
  surname: Barger
  fullname: Barger, Laura K.
  organization: Turner Institute for Brain and Mental Health, Monash University, Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women’s Hospital, Division of Sleep Medicine, Harvard Medical School
– sequence: 5
  givenname: Elise R.
  orcidid: 0000-0003-4549-9266
  surname: Facer-Childs
  fullname: Facer-Childs, Elise R.
  organization: Turner Institute for Brain and Mental Health, Monash University
– sequence: 6
  givenname: Shantha M. W.
  orcidid: 0000-0001-7527-8558
  surname: Rajaratnam
  fullname: Rajaratnam, Shantha M. W.
  organization: Turner Institute for Brain and Mental Health, Monash University, Institute for Breathing and Sleep, Austin Health, Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women’s Hospital, Division of Sleep Medicine, Harvard Medical School
– sequence: 7
  givenname: Charles A.
  orcidid: 0000-0002-7408-1849
  surname: Czeisler
  fullname: Czeisler, Charles A.
  organization: Turner Institute for Brain and Mental Health, Monash University, Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women’s Hospital, Division of Sleep Medicine, Harvard Medical School
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33722226$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu1DAUhiNURC_wAiyQJTbdpPiWGwukqhSoVKkLKFvLsY9nXCX2YDul8348GJ5MSy9CdRZJ7P__Ts7Jv1_sOO-gKN4SfERIW3-IhLZtV2JKSoI5weXNi2KP8IaUlFftzoPn3WI_xiuMSdNW9FWxy1hD86r3ij-nMgxrtJr6wSok9RICOAXot01LJJ1GcVqtfEjI-IBikutSpnLpR0AnFz_PPpekQ6NNdiGT9S4LgkywsBCRhriyCTLyGkIENFgDyI4rqdJHJFEWuuhmlxyQCj7GMoK6fY9TuIZ1xk16jaxDaQno0mWcRt9TrhDnTzueNvUGK18XL40cIry5vR8Ul19Of5x8K88vvp6dHJ-XqsZNKnswipGu7wlTjDKGtTKd7o2kGGpTy56qqjb5kDZ9JbWsteLEVJh1Dc5D5uygONtytZdXYhXsKMNaeGnFvOHDQsiQrBpANJ2qu1rprlOMNzIvzWRP2kZibloOmfVpy8qjH0ErcJteHkEfnzi7FAt_nclVw2uaAYe3gOB_TRCTGG1UMAzSgZ-ioBUmLe8wx1n6_on0yk8hD3pW0a6t2obcqxYyN2Cd8bmu2kDFcV3VnFDONqyj_6jypWG0KgfU2Lz_yPDuYaP_OrzLYBa0W8GcggBGKJvmZGSyHQTBYhN3sY27yH9CzHEXN9lKn1jv6M-a2NYUs9gtINxP4xnXXz_-FjQ
CitedBy_id crossref_primary_10_3390_covid4040031
crossref_primary_10_1007_s11673_023_10255_6
crossref_primary_10_1186_s12889_022_14201_w
crossref_primary_10_1080_07448481_2021_1965610
crossref_primary_10_1002_jcop_23007
crossref_primary_10_1016_j_psychres_2022_114902
crossref_primary_10_1177_13591053231209880
crossref_primary_10_1016_j_jad_2021_12_029
crossref_primary_10_1080_10962247_2023_2185315
crossref_primary_10_1177_15598276231197179
crossref_primary_10_1002_hpja_932
crossref_primary_10_1371_journal_pone_0289547
crossref_primary_10_3390_ijerph191610224
crossref_primary_10_1016_j_sleh_2022_03_001
crossref_primary_10_1017_S204579602100038X
crossref_primary_10_1080_23792949_2024_2448421
crossref_primary_10_3390_ijerph182312302
crossref_primary_10_1016_j_jad_2023_02_115
crossref_primary_10_1177_23333928231154336
crossref_primary_10_1186_s12889_022_13355_x
crossref_primary_10_1371_journal_pone_0283381
crossref_primary_10_1016_j_jpsychires_2021_05_080
crossref_primary_10_1177_18344909231190305
crossref_primary_10_3389_fpsyg_2022_1040518
crossref_primary_10_1016_j_jad_2021_08_130
crossref_primary_10_3390_ijerph192113723
crossref_primary_10_1177_07334648231169086
crossref_primary_10_1097_FCH_0000000000000367
crossref_primary_10_2105_AJPH_2021_306460
crossref_primary_10_1371_journal_pone_0279963
crossref_primary_10_1016_j_amepre_2022_09_014
crossref_primary_10_1016_j_addbeh_2023_107707
crossref_primary_10_1093_geronb_gbab110
Cites_doi 10.2471/BLT.15.158543
10.1016/S0140-6736(20)32545-9
10.1056/nejmp2004211
10.1177/0890117120983982b
10.1192/bjo.2020.109
10.3390/ijerph17051729
10.2196/24614
10.15585/mmwr.mm6924e1
10.1136/thx.2010.152801
10.1016/S1473-3099(20)30120-1
10.1136/bmjopen-2013-004183
10.1177/0748730419886986
10.3201/eid1007.030703
10.15585/mmwr.mm6932a1
10.15585/mmwr.mm6935a2
10.1186/1756-0500-5-377
10.1016/j.jad.2009.06.019
10.1126/science.abb5793
10.1016/j.anr.2012.08.004
10.1158/1055-9965.EPI-19-0846
10.1007/s11606-014-3112-6
10.1186/s12889-021-10379-7
10.1001/jamainternmed.2020.1369
10.3390/ijerph17062032
10.1001/jamanetworkopen.2020.37665
10.1016/S0140-6736(20)30460-8
10.1136/bjsm.2009.068395
10.1001/jamanetworkopen.2020.19686
10.15585/mmwr.mm6915e2
10.1186/1471-2334-11-2
ContentType Journal Article
Copyright The Author(s) 2021
COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2021
– notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T2
7TQ
7X7
7XB
88E
8C1
8FE
8FG
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
AN0
ATCPS
AZQEC
BENPR
BGLVJ
BHPHI
C1K
CCPQU
COVID
DHY
DON
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
L6V
M0S
M1P
M7S
PATMY
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
7X8
5PM
DOA
DOI 10.1186/s12889-021-10410-x
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health and Safety Science Abstracts (Full archive)
PAIS Index
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Proquest Public Health Database
ProQuest SciTech Collection
ProQuest Technology Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central
ProQuest One Sustainability
ProQuest Central UK/Ireland
British Nursing Database (Proquest)
Agricultural & Environmental Science Collection (ProQuest)
ProQuest Central Essentials
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
Coronavirus Research Database
PAIS International
PAIS International (Ovid)
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Engineering Collection
ProQuest Health & Medical Collection
Medical Database
Engineering Database (Proquest)
Environmental Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering collection
Environmental Science Collection
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ (Directory of Open Access Journals)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
ProQuest Engineering Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Agricultural & Environmental Science Collection
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Engineering Database
ProQuest Public Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
Coronavirus Research Database
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Environmental Science Collection
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
PAIS International
Materials Science & Engineering Collection
Environmental Science Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE


MEDLINE - Academic

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1471-2458
EndPage 16
ExternalDocumentID oai_doaj_org_article_79c696cd99c347aaaad3ab187a04f84e
PMC7957462
A656412430
33722226
10_1186_s12889_021_10410_x
Genre Journal Article
GeographicLocations New York City
Los Angeles
Australia
United States
Los Angeles California
United States--US
GeographicLocations_xml – name: New York City
– name: United States
– name: Los Angeles
– name: Australia
– name: Los Angeles California
– name: United States--US
GrantInformation_xml – fundername: Australian-American Fulbright Commission
  funderid: http://dx.doi.org/10.13039/501100001058
– fundername: Turner Institute for Brain and Mental Health
– fundername: National Institute for Occupational Safety and Health
  grantid: R01-OH-010300; R01-OH-010300
  funderid: http://dx.doi.org/10.13039/100000125
– fundername: Commonwealth Scientific and Industrial Research Organisation
  funderid: http://dx.doi.org/10.13039/501100000943
– fundername: Institute for Breahting and Sleep at Austin Health
– fundername: Philips
  funderid: http://dx.doi.org/10.13039/100004320
– fundername: NIOSH CDC HHS
  grantid: R01-OH-010300
– fundername: NHLBI NIH HHS
  grantid: K01 HL150339
– fundername: NIOSH CDC HHS
  grantid: R01 OH010300
– fundername: ;
– fundername: ;
  grantid: R01-OH-010300; R01-OH-010300
GroupedDBID ---
0R~
23N
2WC
2XV
44B
53G
5VS
6J9
6PF
7X7
7XC
88E
8C1
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABJCF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AN0
AOIJS
ATCPS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BGLVJ
BHPHI
BMC
BNQBC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESTFP
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
L6V
M1P
M48
M7S
M~E
O5R
O5S
OK1
OVT
P2P
PATMY
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PTHSS
PUEGO
PYCSY
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7T2
7TQ
7XB
8FK
AZQEC
C1K
COVID
DHY
DON
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c607t-befc319bb13c32330dcf9dbfa20e6f6ab2c56f13c27b5ada6dc41f50397002143
IEDL.DBID M48
ISSN 1471-2458
IngestDate Wed Aug 27 00:56:35 EDT 2025
Thu Aug 21 14:10:07 EDT 2025
Mon Sep 08 16:35:20 EDT 2025
Fri Jul 25 19:15:02 EDT 2025
Tue Jun 17 21:45:35 EDT 2025
Tue Jun 10 20:33:15 EDT 2025
Mon Jul 21 05:52:17 EDT 2025
Thu Apr 24 22:53:40 EDT 2025
Tue Jul 01 00:56:12 EDT 2025
Sat Sep 06 07:35:54 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords COVID-19
SARS-CoV-2
Coronavirus
Insomnia
Mental health
Pandemic
Stay-at-home orders
Qualtrics
Public health policy
Mitigation strategies
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c607t-befc319bb13c32330dcf9dbfa20e6f6ab2c56f13c27b5ada6dc41f50397002143
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-7527-8558
0000-0001-8547-7331
0000-0003-4549-9266
0000-0003-0288-2505
0000-0001-7772-1496
0000-0002-7408-1849
0000-0003-3100-7347
OpenAccessLink https://doi.org/10.1186/s12889-021-10410-x
PMID 33722226
PQID 2502985871
PQPubID 44782
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_79c696cd99c347aaaad3ab187a04f84e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7957462
proquest_miscellaneous_2501849040
proquest_journals_2502985871
gale_infotracmisc_A656412430
gale_infotracacademiconefile_A656412430
pubmed_primary_33722226
crossref_citationtrail_10_1186_s12889_021_10410_x
crossref_primary_10_1186_s12889_021_10410_x
springer_journals_10_1186_s12889_021_10410_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-03-15
PublicationDateYYYYMMDD 2021-03-15
PublicationDate_xml – month: 03
  year: 2021
  text: 2021-03-15
  day: 15
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC public health
PublicationTitleAbbrev BMC Public Health
PublicationTitleAlternate BMC Public Health
PublicationYear 2021
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References N Ghotbi (10410_CR12) 2019; 35
JA Horne (10410_CR11) 1976; 4
10410_CR40
10410_CR41
CDC, National Center for Health Statistics (10410_CR25) 2020
10410_CR27
10410_CR20
10410_CR42
CK Ettman (10410_CR26) 2020; 3
10410_CR43
10410_CR22
S Ebrahim (10410_CR38) 2020; 22
MÉ Czeisler (10410_CR28) 2021; 35
T Van Bortel (10410_CR33) 2016; 94
A Shakil (10410_CR16) 2005; 37
10410_CR18
10410_CR19
A Lasry (10410_CR37) 2020; 69
KM Sherin (10410_CR15) 1998; 30
C Wang (10410_CR29) 2020; 17
M Shevlin (10410_CR31) 2020; 6
CL Chai-Coetzer (10410_CR13) 2011; 66
E Dong (10410_CR1) 2020; S1473–3099
10410_CR30
10410_CR35
K Milton (10410_CR14) 2011; 45
10410_CR36
CA Espie (10410_CR7) 2014; 4
ND Jhummon-Mahadnac (10410_CR17) 2012; 5
ED Dolan (10410_CR10) 2015; 30
CA Miller (10410_CR2) 2020; 29
E-H Lee (10410_CR9) 2012; 6
S Hills (10410_CR21) 2021; 21
10410_CR34
MÉ Czeisler (10410_CR23) 2020; 69
A Moreland (10410_CR39) 2020; 69
10410_CR5
10410_CR4
CDC, National Center for Health Statistics (10410_CR24) 2020
L Hawryluck (10410_CR32) 2004; 10
10410_CR3
B Löwe (10410_CR8) 2010; 122
10410_CR6
References_xml – volume: 94
  start-page: 210
  year: 2016
  ident: 10410_CR33
  publication-title: Bull World Health Organ
  doi: 10.2471/BLT.15.158543
– volume: 4
  start-page: 97
  issue: 2
  year: 1976
  ident: 10410_CR11
  publication-title: Int J Chronobiol
– ident: 10410_CR40
  doi: 10.1016/S0140-6736(20)32545-9
– volume-title: Indicators of anxiety or depression based on reported frequency of symptoms during the last 7 days. Household Pulse Survey
  year: 2020
  ident: 10410_CR24
– ident: 10410_CR35
  doi: 10.1056/nejmp2004211
– volume: 35
  start-page: 301
  issue: 2
  year: 2021
  ident: 10410_CR28
  publication-title: Am J Health Promot
  doi: 10.1177/0890117120983982b
– volume: 6
  start-page: e125
  issue: 6
  year: 2020
  ident: 10410_CR31
  publication-title: BJPsych Open
  doi: 10.1192/bjo.2020.109
– volume: 17
  issue: 5
  year: 2020
  ident: 10410_CR29
  publication-title: Int J Environ Res Public Health
  doi: 10.3390/ijerph17051729
– volume: 22
  issue: 12
  year: 2020
  ident: 10410_CR38
  publication-title: J Med Internet Res
  doi: 10.2196/24614
– ident: 10410_CR22
  doi: 10.15585/mmwr.mm6924e1
– volume: 66
  start-page: 213
  issue: 3
  year: 2011
  ident: 10410_CR13
  publication-title: Thorax.
  doi: 10.1136/thx.2010.152801
– volume: S1473–3099
  start-page: 30120
  issue: 20
  year: 2020
  ident: 10410_CR1
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(20)30120-1
– volume: 4
  issue: 3
  year: 2014
  ident: 10410_CR7
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2013-004183
– volume: 35
  start-page: 98
  issue: 1
  year: 2019
  ident: 10410_CR12
  publication-title: J Biol Rhythm
  doi: 10.1177/0748730419886986
– volume: 10
  start-page: 1206
  year: 2004
  ident: 10410_CR32
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid1007.030703
– volume: 30
  start-page: 508
  issue: 7
  year: 1998
  ident: 10410_CR15
  publication-title: Fam Med
– ident: 10410_CR41
– volume: 69
  start-page: 1049
  year: 2020
  ident: 10410_CR23
  publication-title: MMWR Morb Mortal Wkly Rep
  doi: 10.15585/mmwr.mm6932a1
– ident: 10410_CR5
– volume: 69
  start-page: 1198
  issue: 35
  year: 2020
  ident: 10410_CR39
  publication-title: MMWR Morb Mortal Wkly Rep
  doi: 10.15585/mmwr.mm6935a2
– ident: 10410_CR3
– ident: 10410_CR43
– volume: 5
  start-page: 377
  year: 2012
  ident: 10410_CR17
  publication-title: BMC Res Notes
  doi: 10.1186/1756-0500-5-377
– volume: 122
  start-page: 86
  issue: 1–2
  year: 2010
  ident: 10410_CR8
  publication-title: J Affect Discord
  doi: 10.1016/j.jad.2009.06.019
– ident: 10410_CR36
  doi: 10.1126/science.abb5793
– volume: 6
  start-page: 121
  issue: 4
  year: 2012
  ident: 10410_CR9
  publication-title: Asian Nurs Res
  doi: 10.1016/j.anr.2012.08.004
– volume: 29
  start-page: 731
  issue: 4
  year: 2020
  ident: 10410_CR2
  publication-title: Cancer Epidemiol Biomark Prev
  doi: 10.1158/1055-9965.EPI-19-0846
– volume: 30
  start-page: 582
  issue: 5
  year: 2015
  ident: 10410_CR10
  publication-title: J Gen Intern Med
  doi: 10.1007/s11606-014-3112-6
– volume: 21
  start-page: 352
  issue: 1
  year: 2021
  ident: 10410_CR21
  publication-title: BMC Public Health
  doi: 10.1186/s12889-021-10379-7
– ident: 10410_CR20
  doi: 10.1001/jamainternmed.2020.1369
– ident: 10410_CR19
– ident: 10410_CR30
  doi: 10.3390/ijerph17062032
– volume-title: Early release of selected mental health estimates based on data from the January–June 2019 National Health Interview Survey
  year: 2020
  ident: 10410_CR25
– volume: 37
  start-page: 193
  issue: 3
  year: 2005
  ident: 10410_CR16
  publication-title: Fam Med
– ident: 10410_CR27
  doi: 10.1001/jamanetworkopen.2020.37665
– ident: 10410_CR34
  doi: 10.1016/S0140-6736(20)30460-8
– volume: 45
  start-page: 203
  issue: 3
  year: 2011
  ident: 10410_CR14
  publication-title: Br J Sports Med
  doi: 10.1136/bjsm.2009.068395
– volume: 3
  issue: 9
  year: 2020
  ident: 10410_CR26
  publication-title: JAMA Netw Open
  doi: 10.1001/jamanetworkopen.2020.19686
– volume: 69
  start-page: 451
  issue: 15
  year: 2020
  ident: 10410_CR37
  publication-title: MMWR Morb Mortal Wkly Rep
  doi: 10.15585/mmwr.mm6915e2
– ident: 10410_CR18
  doi: 10.1186/1471-2334-11-2
– ident: 10410_CR6
– ident: 10410_CR42
– ident: 10410_CR4
SSID ssj0017852
Score 2.4905837
Snippet Background Governments worldwide recommended unprecedented measures to contain the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute...
Governments worldwide recommended unprecedented measures to contain the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory...
Background Governments worldwide recommended unprecedented measures to contain the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute...
Abstract Background Governments worldwide recommended unprecedented measures to contain the coronavirus disease 2019 (COVID-19) pandemic, caused by severe...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 503
SubjectTerms Adolescent
Adult
Adults
Age
Aged
Anxiety
Australia
Australia - epidemiology
Biostatistics
CFR
Cities
Communicable Disease Control - methods
Compliance
Consent
Control
Coronaviridae
Coronavirus
Coronaviruses
COVID-19
COVID-19 - epidemiology
COVID-19 - mortality
COVID-19 - prevention & control
COVID-19 - psychology
Cross-Sectional Studies
Disease Outbreaks - prevention & control
Environmental Health
Epidemics
Epidemiology
Ethnicity
Female
Gender
Health aspects
Health behavior
Humans
Infectious Disease epidemiology
Infectious diseases
Influence
Insomnia
Life Style
Los Angeles - epidemiology
Male
Measures
Medicine
Medicine & Public Health
Mental Health
Middle Aged
Mitigation strategies
Mortality rates
New York City - epidemiology
Pandemic
Pandemics
Policies
Polls & surveys
Public Health
Public Health - legislation & jurisprudence
Public officials
Public Opinion
Quarantine
Questionnaires
Quotas
Regions
Research Article
Respiratory diseases
Respondents
Response rates
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Shelter in place
Signs and symptoms
Sleep apnea
Stay-at-home orders
Surveillance
Surveys
Surveys and Questionnaires
Transnationalism
United States
United States - epidemiology
Vaccine
Variables
Viral diseases
Young Adult
SummonAdditionalLinks – databaseName: DOAJ (Directory of Open Access Journals)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT0gI8SZQ0CAhcYCoiZ3YMbdSqAoHuFDUm-WnulKbrZosav8fP4yxnSzdIuBCbokda2yPx5_tmc-EvGR14FS4urROtmXDQleaaAzjwavhhnY-e_l-5geHzaej9ujKVV_RJyzTA-eG2xHScsmxJGlZIzQ-jmlTd0JXTegaH61vJat5MTWdH4iupXOITMd3BrTC0TWIRvetBi3PxcY0lNj6f7fJVyal6w6T105N02S0f4fcnlAk7Gbp75Ibvr9HbuUtOMiRRffJj0ReDJnIGrQ7zpF9ELdeQfcOhtVZRN-AuBUQJF6WeiyPl6ce9r58-_i-rCWcLjIFx7KHYZxJJcDF4_nRY5HRp8PDySJ4yOGWb0HDGKe_eZMRUv3LIXl8xfdhdf7dX0KitYVFDwhAIQNfyMA3ibbegnlADvc_fN07KKdLG0rLKzGWxgeLw9qYmllGGaucDdKZoGnleeDaUNvygIlUmFY7zZ1t6tBWiIsSfxt7SLb6Ze8fE3B1CMZTYR0PjRBGBumlk51pg2ChlQWp5z5UdmI0jxdrnKi0sum4yv2usFyV-l1dFOT1-p-zzOfx19zvomqsc0Yu7vQBNVRNGqr-paEFeRUVS0WLgeJZPQU-YCUj95baRUgd7wBnVUG2N3LiSLebybNqqsnSDAohLJVdi-vegrxYJ8c_o_dc75erlAcX8hLtdUEeZU1eV4kxgRCR8oKIDR3fqPNmSr84TjzkQrai4bQgb-bR8EusP7fpk__Rpk_JTRpHc3SsbLfJ1ni-8s8QHY7meTIEPwG0ImUZ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1db9MwFLVG94KEEN8EBjISEg8QLbETO0ZCaBubBg8DIYb2FvmTVtrS0qZo-3_8MHztJCNDrG-tnchu7j0-se89F6GXNHeMcJOn2ogyLairUgVgCAeviilS2Rjle8QOj4tPJ-XJBjrqc2EgrLLHxADUZq5hj3zbL9VEVKXn9-8XP1OoGgWnq30JDdmVVjDvgsTYDbTpIbnMJmhzd__oy9fhXIFXJelTZyq2vfLoDCFDBMK6Co9I56PlKaj4_4vVfy1WVwMpr5ymhkXq4A663bFLvBPN4S7asM09dCtuzeGYcXQf_Q6ixjgKXGNppjHjD8OWLJaNwav1Alg59nwWe_J4kco2nc7PLN77_P3jhzQX-GwWpTnmDV61vdgENnBs31p_S4j1sPh05iyOaZhvscQtLIv95iMO809XIRIMvq_Wy1_2Age5WzxrsCemOBJiHAlxGNqwNfMAHR_sf9s7TLtiDqlmGW9TZZ327q5UTjUllGZGO2GUkySzzDGpiC6Z842Eq1IayYwucldmni8FXTf6EE2aeWMfI2xy55QlXBvmCs6VcMIKIypVOk5dKRKU98-w1p3SORTcOK3DG0_F6vjca3_fOjz3-jxBr4drFlHn49reu2AaQ0_Q6A4_zJc_6s7lay40E8z7gNC04NJ_DJUqr7jMClcVNkGvwLBqQBI_PC27hAg_SdDkqnc81Yba4DRL0Naop0cAPW7uTbPuEGhVX_pLgl4MzXAlRNU1dr4OffwLvvA4nqBH0ZKHKVHKPXUkLEF8ZOOjOY9bmtk06JNzUfKCkQS96b3hclj__0-fXD-Lp-gmAT-FUMpyC03a5do-83ywVc87J_8DWntiRA
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9UwFA8yQQQRnV_VKREEH7R4mzRJ49u8OqagvjjZW8gnu7D1jrVX3P_nH-ZJ0tZ1foB9a5OUpD3n5Jecc35B6BmtAifCVaV1kpU1DU1pojGMjlfDDWl8jvL9xPcP6g-H7HCgyYm5MBf991XDX3VgP2NQD4mBVzXYDMCLVxkY3ijNS76cPAaiYWRMivlju9nEk_j5f7fCF6ahyyGSl_ykafrZu4VuDrgR7-YffRtd8e02uvZx8Ixvoxt5_w3ntKI76EdiLsaZxRprd5TT-nDcd8W6dbjbnEbojQG0YkCI56Xuy6P1icfLz1_fvy0riU9WmX9j3eKuHxklsIu--d7DK2NAh8fHq-BxzrV8jTXu49w37jDi9CnKLoV7xftuc_bNn-PEaYtXLQb0iTPqxRn1pq5N-y930cHeuy_L_XI4saG0fCH60vhgQaeNqailhNKFs0E6EzRZeB64NsQyHqCQCMO009zZugpsAaAokbfRe2irXbf-AcKuCsF4IqzjoRbCyCC9dLIxLAgamCxQNf5OZQc683iqxrFKy5qGqywCCt6rkgio7wV6MbU5zWQe_6z9JkrJVDMScacHIJ9q0GslpOWSg6BLS2uh4XJUm6oRelGHpvYFeh5lTEVzAd2zesh6gEFG4i21C3g6HgBOFwXamdUENbfz4lFK1WBmOgX4lciGwaK3QE-n4tgyhs61fr1JdWAVL8FYF-h-FuppSJQKwIeEF0jMxH025nlJuzpKJORCMlFzUqCXo2L86tbfv-nD_6v-CF0nUYVj_CTbQVv92cY_BhDYmydJ-38CZvhYPQ
  priority: 102
  providerName: Springer Nature
Title Early public adherence with and support for stay-at-home COVID-19 mitigation strategies despite adverse life impact: a transnational cross-sectional survey study in the United States and Australia
URI https://link.springer.com/article/10.1186/s12889-021-10410-x
https://www.ncbi.nlm.nih.gov/pubmed/33722226
https://www.proquest.com/docview/2502985871
https://www.proquest.com/docview/2501849040
https://pubmed.ncbi.nlm.nih.gov/PMC7957462
https://doaj.org/article/79c696cd99c347aaaad3ab187a04f84e
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLbGJqFJCHEnMCojIfEAgcZO7BgJoa1sDB4GmiiaeIniG6u0paNN0fb_-GGcYzfdCht9sJTYjmz3XD7bx58JecYzL5i0WWqsKtKc-zLVaAxx41ULzUoXo3z3xO4w_3RQHKyQ7rqj-QBOL53a4X1Sw8nRq9OfZ-9A4d8GhS_F6ynYWAz8YRiclYNdAUy5FvaLMJQvP99VkGXBuoMzl9ZbJ9c5l-AykWvhgp8KdP7_Gu0LXuvviMq_tlWDt9q5RW7OYSbdjHJxm6y45g65EdfoaDx6dJf8DuzGNDJd09oexqN_FNdmad1YOp2d4MhQALYUUORZWrfp4fjY0cHnbx_fp5mix6PI0TFu6LTtWCeoxf371sEnMejD0aORdzSex3xDa9qif-xWIWnofzoNIWH4PJ1NfrkzGnhv6aihgFBpRMY0IuPQtMUazT0y3Nn-OthN57c6pEb0ZZtq5w3ovdYZN5xx3rfGK6t9zfpOeFFrZgrhIZNJXdS2FtbkmS_6AJwCwRu_T1abceMeEmoz77Vj0ljhcym18sopq0pdeMl9oRKSdf9hZeaU53jzxlEVpj6lqKIIVPDdKohAdZqQF4s6J5Hw47-lt1A0FiWRrDu8GE9-VHPdr6QyQglQBmV4Lmv4WV7rrJR1P_dl7hLyHAWrQiGH5pl6fjICOonkXNUmYG68JJz3E7KxVBJMgVnO7kSz6jSpAozLVFnAxDghTxfZWBPD6xo3noUyMNNXYNAT8iBK8qJLnUIkRC7J-FKfl3Oa0WEgKpeqkLlgCXnZacN5s64e00dXNuExWWeorRhOWWyQ1XYyc08AE7a6R67JAwlpOcgw3fnQI2tb23tf9uFpIAa9sNbSC-YA0v2t75AO2eYfcSVm2g
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKewAJId4EChgJxAGibpzEjpEq1KdaWgpCFPVm_KQrtdnSZKH9c5z4YXjsZMsW0Vtz29ixPOvxzHg88w1Cz_PMUcJMlmrDy7TIXZUqEIZw8aqoIpWNUb47dGO3eLdX7s2gX30uDIRV9jIxCGoz0uAjX_CqmvCq9Pb926PvKVSNgtvVvoSG7EormMUAMdYldmzZ05_-CNcsbq769X5ByPra55WNtKsykGo6YG2qrNOeD5XKcp0Tf7w32nGjnCQDSx2ViuiSOt9ImCqlkdToInPlwCvyADiW-3GvoLkCHCizaG55befjp8k9BqtK0qfqVHSh8doAQpQIhJEVXgKeTKnDUDXgX93wl3I8H7h57vY2KMX1m-hGZ83ipch-t9CMrW-j69EViGOG0x30O4Ao4wiojaXZjxmGGFzAWNYGN-MjOAVgbz9jb6yeprJN90eHFq98-LK5mmYcHw4jFMioxk3bg1tgA2ECrfVDQmyJxQdDZ3FM-3yDJW5BDffOThzoT5sQeQa_m_HxD3uKA7wuHtbYG8I4GuA4GuBhahNX0F20eynLeg_N1qPaPkDYZM4pS5g21BWMKe645YZXqnQsdyVPUNavodAdsjoU-DgQ4YRVURHXXfhxRVh3cZKgV5NvjiKuyIW9l4E1Jj0BEzy8GB1_E52IEYxryqnfc1znBZP-MblUWcXkoHBVYRP0EhhLgOTy09OyS8DwRAIGmFjypj3UIs8HCZqf6ukljp5u7llTdBKvEWf7M0HPJs3wJUTx1XY0Dn2yquBebyTofuTkCUl5zrypSmiC2BSPT9E83VIP9wMeOuMlKyhJ0Ot-N5xN6___6cOLqXiKrm58fr8ttjd3th6hawT2LIRxlvNotj0e28feFm3Vk27DY_T1smXMH278oCM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Zb9QwELZQkSokhKBcgQJGQuIBoiZ2Yse8LS2rlqPwwKK-WT7ZldrsapNF9P_xw_CRhKYcEnlLbEd2MjP-7Jn5DMAznFuCqM5TpVmZFthWqfTG0DteJZGoMjHK95gczoq3J-XJhSz-EO3euyRjToNnaarbvZW2UcUrstc4q-pDfZAPxyqcJXEo8mrh5mof1DVDk8GPQKsS9akyf2w3mo4Ca__vtvnC5HQ5cPKS9zRMStOb4EaHJuEk_v5b4Iqpd8D2h85fvgOux105GJONboMfgc8YRm5rKPQ8JvtBvxsLRa1hs1l5QA4dlIUON56nok3nyzMD9z9-OTpIcwbPFpGVY1nDpu15JqD2HvvWuFf6MA8DTxfWwJiB-QoK2PoZsd93hOFTpE0IAvP3zWb9zZzDwHQLFzV0mBRGLAwjFg5dG3Zl7oDZ9M3n_cO0O8chVSSjbSqNVU7TpcyxwgjjTCvLtLQCZYZYIiRSJbGuEFFZCi2IVkVuy8xBpUDphu-CrXpZm_sA6txaaRBVmtiCUsksM0yzSpaWYluyBOT97-SqIzn3Z22c8rDYqQiPIsDde3kQAf49AS-GNqtI8fHP2q-9lAw1PT13eLBcf-WdtnPKFGHEiT9TuKDCXRoLmVdUZIWtCpOA517GuDcirntKdLkQbpCejotPHMr2x4LjLAG7o5pO-dW4uJdS3hmfhjtUi1hVuqVwAp4Oxb6lD6irzXIT6ri1PXMmPAH3olAPQ8KYOtSISALoSNxHYx6X1It5oCanrKQFQQl42SvGr279_Zs--L_qT8D2p4Mpf390_O4huIa8NvsAy3IXbLXrjXnkUGIrHwdD8BPU0GOS
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Early+public+adherence+with+and+support+for+stay-at-home+COVID-19+mitigation+strategies+despite+adverse+life+impact%3A+a+transnational+cross-sectional+survey+study+in+the+United+States+and+Australia&rft.jtitle=BMC+public+health&rft.au=Czeisler%2C+Mark+%C3%89&rft.au=Howard%2C+Mark+E&rft.au=Robbins%2C+Rebecca&rft.au=Barger%2C+Laura+K&rft.date=2021-03-15&rft.eissn=1471-2458&rft.volume=21&rft.issue=1&rft.spage=503&rft_id=info:doi/10.1186%2Fs12889-021-10410-x&rft_id=info%3Apmid%2F33722226&rft.externalDocID=33722226
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2458&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2458&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2458&client=summon